Stock listing

GPW:PTG PolTREG Spolka Akcyjna Akcje

Follow PolTREG Spolka Akcyjna into a list and get an email when it puts out news.

Share price · GPW:PTG

21.30 PLN +0.90 (+4.4%)

Close on Oct 30, 2026

Past year -17.1% · daily closes, Oct 30, 2025 – Oct 30, 2026, adjusted for splits
Day range
19.80 – 21.30 PLNOct 30, 2026
Volume
6,025 sharesOct 30, 2026
Market cap
126.0M PLNAt the close on Oct 30, 2026 · price × 5.92M shares outstanding
52-week range
16.00 – 29.50 PLNLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
Traded on an average day
104,929 PLNMedian day 3,356 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
PolTREG Spolka Akcyjna logo

Daily closes

Last 3 months, Jul 30, 2026 – Oct 30, 2026 · GPW:PTG · PLN, adjusted for splits

DayCloseChange%OpenHighLowVolume
21.30+0.90+4.4%20.2021.3019.806,025
20.40-0.20-1.0%20.7020.7019.257,073
20.600.000.0%20.5020.6019.801,698
20.60+0.50+2.5%19.7020.6019.501,980
20.100.000.0%20.1020.1019.351,332
20.10-0.50-2.4%20.1020.2019.80111
20.60-0.60-2.8%20.3021.0020.002,659
21.20+1.50+7.6%20.9021.2020.003,644
19.70-0.20-1.0%20.2021.2019.653,398
19.90+0.35+1.8%19.1520.2019.153,356
19.55+0.55+2.9%19.7019.7019.10180
19.00-0.55-2.8%20.0020.0019.003,072
19.55-0.95-4.6%20.2020.4019.55252
20.50+0.75+3.8%19.8020.5019.152,617
19.75+0.25+1.3%19.0019.7519.00539
19.50-0.05-0.3%20.1020.2019.0012,094
19.55-0.45-2.2%20.0020.2019.552,015
20.00-0.30-1.5%19.6520.2019.65807
20.30-0.10-0.5%20.3020.3019.901,107
20.40+0.10+0.5%20.0020.4019.202,474
20.30-0.10-0.5%20.4020.4020.001,287
20.40-0.10-0.5%19.8020.7019.604,187
20.50-0.40-1.9%21.1021.2019.9510,393
20.90-0.80-3.7%21.6021.6020.008,180
21.70+0.40+1.9%21.5021.7020.005,955
21.30+0.60+2.9%20.8021.3020.502,176
20.70+0.60+3.0%20.1020.7019.652,511
20.10-0.20-1.0%20.0020.2019.108,574
20.30-0.20-1.0%20.0020.7019.801,566
20.50-0.50-2.4%20.2021.1019.958,387
21.000.000.0%20.5021.4020.102,206
21.00-0.70-3.2%21.4021.7019.7013,345
21.70-0.20-0.9%22.0022.0021.501,078
21.90-1.00-4.4%22.9023.0021.904,366
22.90+0.10+0.4%22.2022.9021.203,669
22.80+0.40+1.8%22.3022.8022.001,453
22.40+0.10+0.4%22.3022.4022.101,118
22.30-0.90-3.9%23.2023.2022.104,311
23.20+1.00+4.5%22.7023.2022.104,316
22.20+0.30+1.4%22.3023.4022.208,419
21.90-0.20-0.9%22.2022.3021.90648
22.10-1.00-4.3%23.1023.1021.806,720
23.10+0.40+1.8%22.7023.3022.103,019
22.70-0.80-3.4%23.5023.5022.006,215
23.50-0.10-0.4%23.0023.6022.702,664
23.600.000.0%23.0023.6023.002,903
23.60-0.10-0.4%23.2024.2022.804,667
23.70-1.30-5.2%24.7024.7022.5019,983
25.00-0.20-0.8%25.0025.5024.0012,502
25.20-1.40-5.3%26.4026.7024.509,828
26.60+0.10+0.4%26.5026.7025.601,685
26.50+0.90+3.5%25.6026.5025.301,523
25.60-0.30-1.2%25.0025.6024.706,280
25.90-0.30-1.1%26.2026.4025.501,947
26.20-0.40-1.5%26.8026.8026.103,736
26.60-0.30-1.1%26.5027.0026.102,187
26.900.000.0%26.9027.0026.506,048
26.900.000.0%26.9027.0026.705,491
26.90+0.90+3.5%26.0026.9025.806,374
26.00+0.20+0.8%26.1026.1025.301,813
25.80-0.20-0.8%26.0026.0025.302,220
26.00+0.20+0.8%25.9026.1025.503,637
25.80+0.80+3.2%25.0025.9025.0016,629
25.00+0.70+2.9%23.6025.2023.609,450
24.30+0.30+1.3%24.0024.3023.805,087
24.000.000.0%24.0024.0023.002,194
24.00+1.10+4.8%22.9024.0022.108,256
Ticker
GPW:PTG
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
GPW
Currency
PLN

What changed lately

Latest news

PolTREG moves forward with the European registration process for TREG therapy in type 1 diabetes

Mar 10, 2026

Closed 24.10 (-1.6%) on Mar 10, 2026

PolTREG Doses First Patient in Phase II Trial for Pre-Symptomatic Type 1 Diabetes with PTG-007

Aug 4, 2025

PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial

Jul 31, 2025

PolTREG Establishes U.S. Subsidiary Immuthera to Advance International Development Strategy

Jun 13, 2025

Positive EMA Opinion on Pediatric Investigation Plan for PolTREG’s Treg Therapy in Type 1 Diabetes

May 15, 2025

PolTREG launches Phase 2 cell therapy trial in children with presymptomatic diabetes

Oct 24, 2024

PolTREG starts preclinical CAR-Treg development for neuroinflammatory autoimmune diseases

Sep 26, 2024

China patent notification boosts PolTREG’s development of Treg cell therapy in multiple sclerosis

Sep 16, 2024

PolTREG Treg cell therapy for patients with type-1 diabetes shows long-term clinical remission and insulin independence

Sep 9, 2024

PolTREG’s type-1 diabetes Treg cell therapy PTG-007 demonstrates long-term safety and efficacy for up to 12 years

Jun 24, 2024

All PolTREG Spolka Akcyjna news

Decks

PolTREG Spolka Akcyjna on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in the last 12 months · 15 in all · newest Mar 10, 2026 · oldest 2024
Decks
5 decks · latest February 2026

Log in to ask 6ix AI your own questions about PolTREG Spolka Akcyjna.